标题
Glucagon-like peptide 1 receptor agonists in type 1 diabetes mellitus
作者
关键词
-
出版物
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
Volume 76, Issue 21, Pages 1739-1748
出版商
Oxford University Press (OUP)
发表日期
2019-10-15
DOI
10.1093/ajhp/zxz179
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Addition of GLP-1 Therapy to Insulin in C-Peptide-Positive Patients with Type 1 Diabetes
- (2018) NITESH D. KUHADIYA et al. DIABETES
- Liraglutide as an Additional Treatment to Insulin in Patients with Type 1 Diabetes Mellitus—A 52-Week Randomized Double-Blinded Placebo-Controlled Clinical Trial
- (2018) PARESH DANDONA et al. DIABETES
- Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial
- (2016) Bo Ahrén et al. DIABETES CARE
- Addition of Liraglutide to Insulin in Patients With Type 1 Diabetes: A Randomized Placebo-Controlled Clinical Trial of 12 Weeks
- (2016) Nitesh D. Kuhadiya et al. DIABETES CARE
- Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial
- (2016) Chantal Mathieu et al. DIABETES CARE
- Obesity and glycemic control in patients with diabetes mellitus: Analysis of physician electronic health records in the US from 2009–2011
- (2016) J.P. Bae et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial
- (2016) Thomas Fremming Dejgaard et al. Lancet Diabetes & Endocrinology
- Type 1 Diabetes Treatment Beyond Insulin
- (2016) Lindsay B. Harrison et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Twelve-Week Treatment With Liraglutide as Add-on to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blind Parallel Study
- (2015) Christian S. Frandsen et al. DIABETES CARE
- Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry
- (2015) Kellee M. Miller et al. DIABETES CARE
- Once-Weekly Exenatide as Adjunct Treatment of Type 1 Diabetes Mellitus in Patients Receiving Continuous Subcutaneous Insulin Infusion Therapy
- (2014) Andrea N. Traina et al. Canadian Journal of Diabetes
- Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes: A randomized, open label study
- (2013) K.V.S. Hari Kumar et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Liraglutide as Additional Treatment to Insulin in Obese Patients with Type 1 Diabetes Mellitus
- (2013) Nitesh Kuhadiya et al. Endocrine Practice
- Four Weeks of Treatment With Liraglutide Reduces Insulin Dose Without Loss of Glycemic Control in Type 1 Diabetic Patients With and Without Residual -Cell Function
- (2011) U. Kielgast et al. DIABETES CARE
- Liraglutide as additional treatment for type 1 diabetes
- (2011) Ajay Varanasi et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Hypoglycemia in Type 1 Diabetes
- (2010) R. J. McCrimmon et al. DIABETES
- The Role of Adjunctive Exenatide Therapy in Pediatric Type 1 Diabetes
- (2010) V. S. Raman et al. DIABETES CARE
- Effects of Exenatide Alone and in Combination With Daclizumab on -Cell Function in Long-Standing Type 1 Diabetes
- (2009) K. I. Rother et al. DIABETES CARE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search